We are excited to publish on our Phage-mimicking nanoparticles efficiently tackling Group A Streptococcus infections in mouse wound infection models in RSC Nanoscale Advances (https://pubs.rsc.org/en/content/articlepdf/2024/NA/D3NA00620D). Thank you to Prof. Frank Castellino, Prof. Victoria Ploplis, and Deborah Donahue of the W.M. Keck Transgene Center for the in vivo studies. Thanks to Prof. Shaun Lee’s lab (Biology) for sharing their antimicrobial peptide library with us. This was truly a team effort by the technical staff and undergraduate researchers with the graduate student (Johanna Olesk) to get the data necessary to publish this work. The Indiana-CTSI project development team fund initiated this collaboration. The work was sustained by the Berthiaume Institute for Precision Health funding and the American Cancer Society’s Institutional Research Grant. This work highlights the quality research contributions made by Notre Dame Undergraduates. Conor Sheehan, Kevin Armknecht, and Zach Bennett are all undergraduate researchers. Conor Sheehan (NURF’22) and Kevin Armknecht (NURF’23) had summer undergraduate research fellowships from NDNnano. Johanna Olesk (MS-BioE’23) had a Materials Science and Engineering Fellowship in 2023. We are thankful for the support from BIPH UNDresearch and CTSI Indiana for bringing this publication to fruition. Congratulations to all the authors for this fantastic work.
Jan 29
Phage-Mimicking Antibacterial Nanoparticles Tackle Group A Streptococcal Infections In Vivo
Categories:
American Cancer Society, Berthiaume Institute for Precision Health, Hybrid nanoparticles, Indiana Clinical Translational Sciences Institute (I-CTSI), multidrug resistance
by Prakash
This post has no tag
Recent Posts
- Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL) August 30, 2024
- Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa August 21, 2024
- Precision Health and Diagnostics Session Chair at Techconnect World Innovation Conference (2024) June 19, 2024
- MTEC Annual meeting in Baltimore MD (May 24, 2024) May 24, 2024
- Nallathamby Lab’s Kevin Armknecht is Invited to Present at the Midwest Microscopy and Microanalysis Workshop 2024 May 7, 2024
Archives
Categories
NIH Funding Opportunities
- Coordination Center for the Alzheimers Disease Sequencing Project Consortium (U01 Clinical Trial Not Allowed) December 9, 2024Funding Opportunity RFA-AG-25-015 from the NIH Guide for Grants and Contracts. The purpose of this NOFO is to invite applications for the Coordination Center for the Alzheimers Disease Sequencing Project (ADSP) consortium. The ADSP Coordination Center will provide leadership and technical expertise in all aspects of ADSP research. The ADSP Coordination Center will lead and […]
- Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) December 9, 2024Funding Opportunity PAR-24-289 from the NIH Guide for Grants and Contracts. This Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) PAR, a re-issue of PAR-23-025, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V are the only changes […]
- Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) December 9, 2024Funding Opportunity PAR-24-287 from the NIH Guide for Grants and Contracts. This Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03), a re-issue of PAR-22-119, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V are the […]
- Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) December 9, 2024Funding Opportunity PAR-25-230 from the NIH Guide for Grants and Contracts. This Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) PAR, a re-issue of PAR-23-026, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V are the only changes […]
- Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed) December 9, 2024Funding Opportunity PAR-25-330 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research to define the impact of defective HIV proviruses on mechanisms of HIV persistence and pathogenesis during antiretroviral treatment and their potential deleterious effects on HIV cure strategies and interference with HIV-specific […]
- Intramural Loan Repayment Program for AIDS Research (AIDS-LRP) December 9, 2024Notice NOT-OD-25-028 from the NIH Guide for Grants and Contracts
- Notice of Change to Application Instructions for PAR-22-077, NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional) December 9, 2024Notice NOT-AG-24-063 from the NIH Guide for Grants and Contracts
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) December 9, 2024Funding Opportunity PAR-25-141 from the NIH Guide for Grants and Contracts. This NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) PAR, a re-issue of PAR-24-208, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V. Application Review Information of the […]
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) December 9, 2024Funding Opportunity PAR-24-280 from the NIH Guide for Grants and Contracts. This Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V are the only changes […]
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) December 9, 2024Funding Opportunity PAR-24-279 from the NIH Guide for Grants and Contracts. This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplify Review changes in Section V […]
Recent Comments